Citigroup’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
17,508
-17,750
| -50% | -$104K | ﹤0.01% | 3665 |
|
|
2025
Q1 | $296K | Sell |
35,258
-4,326
| -11% | -$36.3K | ﹤0.01% | 3211 |
|
|
2024
Q4 | $295K | Buy |
39,584
+4,162
| +12% | +$31K | ﹤0.01% | 3339 |
|
|
2024
Q3 | $205K | Buy |
35,422
+17,923
| +102% | +$104K | ﹤0.01% | 3565 |
|
|
2024
Q2 | $116K | Buy |
17,499
+9,937
| +131% | +$66.1K | ﹤0.01% | 3417 |
|
|
2024
Q1 | $98.7K | Buy |
7,562
+1,030
| +16% | +$13.4K | ﹤0.01% | 3566 |
|
|
2023
Q4 | $83.3K | Buy |
6,532
+6,421
| +5,785% | +$81.9K | ﹤0.01% | 3535 |
|
|
2023
Q3 | $1.46K | Sell |
111
-14,357
| -99% | -$188K | ﹤0.01% | 4274 |
|
|
2023
Q2 | $370K | Buy |
14,468
+14,050
| +3,361% | +$359K | ﹤0.01% | 2919 |
|
|
2023
Q1 | $10.5K | Sell |
418
-222
| -35% | -$5.59K | ﹤0.01% | 4047 |
|
|
2022
Q4 | $14.7K | Sell |
640
-274
| -30% | -$6.3K | ﹤0.01% | 4011 |
|
|
2022
Q3 | $20K | Sell |
914
-1,632
| -64% | -$35.7K | ﹤0.01% | 4032 |
|
|
2022
Q2 | $37K | Buy |
2,546
+957
| +60% | +$13.9K | ﹤0.01% | 3992 |
|
|
2022
Q1 | $30K | Sell |
1,589
-6,624
| -81% | -$125K | ﹤0.01% | 4235 |
|
|
2021
Q4 | $153K | Buy |
8,213
+6,899
| +525% | +$129K | ﹤0.01% | 3748 |
|
|
2021
Q3 | $35K | Buy |
1,314
+484
| +58% | +$12.9K | ﹤0.01% | 4203 |
|
|
2021
Q2 | $26K | Buy |
+830
| New | +$26K | ﹤0.01% | 4488 |
|